Fortress Biotech Q2 EPS $(0.73) Beats $(1.23) Estimate, Sales $14.90M Beat $14.77M Estimate
Fortress Biotech Q2 EPS $(0.73) Beats $(1.23) Estimate, Sales $14.90M Beat $14.77M Estimate
Fortress Biotech第二季度每股收益爲$(0.73)，超過$(1.23)的預估，銷售額爲1490萬美元，超過1477萬美元的預估。
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.73) per share which beat the analyst consensus estimate of $(1.23) by 40.65 percent. This is a 80 percent increase over losses of $(3.65) per share from the same period last year. The company reported quarterly sales of $14.90 million which beat the analyst consensus estimate of $14.77 million by 0.83 percent. This is a 14.32 percent decrease over sales of $17.39 million the same period last year.
Fortress biotech (納斯達克:FBIO) 報告每股虧損$(0.73)，超過分析師共識預測$(1.23)的40.65%。這比去年同期每股虧損$(3.65)增長了80%。公司報告季度銷售額1490萬美元，擊敗分析師一致預期1477萬美元的0.83%。這是去年同期17.39%銷售額1739萬美元的14.32%下降。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。